College of Marine Life Sciences, Ocean University of China, Qingdao, 266003, People's Republic of China.
J Mater Sci Mater Med. 2012 Dec;23(12):2945-52. doi: 10.1007/s10856-012-4747-7. Epub 2012 Aug 14.
Carboxymethyl chitosan (CM-chitosan) is one of water-soluble derivatives of chitosan. Numerous studies have been focused on its applications as pharmaceutical excipient, bioactive reagent and nontoxic drug carrier. Like other polysaccharides, CM-chitosan is inhomogenous in molecular weight. Originations and preparation procedures considerably influence its molecular weight and molecular weight distributions. Understanding the molecular weight related biological behaviour of this inhomogenous glycopolymer in vivo were crucial for the quality control and clinical applications of chitosan and chitosan based medical devices. In this study, we investigated the effects of molecular weights on the absorption, distribution, degradation and urinary excretion of the fluorescein isothiocyanate-labeled CM-chitosan in rats. The results indicated that molecular weight significantly influenced the uptake of CM-chitosan from the lumen of abdomen and blood vessels to peripheral tissues, the distribution of this chemical and urinary excretion after intraperitoneal administration. These findings provided an important reference for the clinical applications of this versatile derivative of chitosan as postsurgical and other biomedical materials and important clues for the exploitation of CM-chitosan based drug targeting and delivery systems.
羧甲基壳聚糖(CM-壳聚糖)是壳聚糖的一种水溶性衍生物。大量研究集中在其作为药物赋形剂、生物活性试剂和无毒药物载体的应用上。与其他多糖一样,CM-壳聚糖的分子量不均一。来源和制备工艺极大地影响其分子量和分子量分布。了解这种不均一糖聚合物在体内与分子量相关的生物学行为,对于壳聚糖和基于壳聚糖的医疗器械的质量控制和临床应用至关重要。在这项研究中,我们研究了分子量对荧光素异硫氰酸酯标记的 CM-壳聚糖在大鼠体内吸收、分布、降解和尿排泄的影响。结果表明,分子量显著影响 CM-壳聚糖从腹腔内腔和血管到周围组织的摄取、这种化学物质的分布以及腹腔内给药后的尿排泄。这些发现为该多功能壳聚糖衍生物作为术后和其他生物医学材料的临床应用提供了重要参考,并为开发基于 CM-壳聚糖的药物靶向和递药系统提供了重要线索。